Exarta Therapeutics
PrivateLast Round
Seed
Oct 1, 2021
Company Overview
Exarta Therapeutics operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in October 2021.
Exarta Therapeutics is a biotechnology company focused on the development of small molecule drugs for the treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exarta Therapeutics Comparables
Compare Exarta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prothegen Inc. | 92% | |
| Sonata Therapeutics | 85% | |
| BridgeBio Pharma, Inc. | 77% |
For institutional investors. Book with your work email.
Exarta Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Exarta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Viva BioInnovator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2021
Seed round with Viva BioInnovator as investor.
For institutional investors. Book with your work email.
Exarta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Exarta Therapeutics's valuation, stock price, and market status.
Is Exarta Therapeutics a public or private company?
Exarta Therapeutics is a private company.
What is the current stock price of Exarta Therapeutics?
Exarta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Exarta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Exarta Therapeutics worth (valuation)?
Valuation information for Exarta Therapeutics is not publicly available.
Can I buy Exarta Therapeutics stock?
Exarta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Exarta Therapeutics's last funding round?
Exarta Therapeutics's most recent funding round was Seed on October 1, 2021.
Who are the main investors in Exarta Therapeutics?
Key investors in Exarta Therapeutics include Viva BioInnovator.
Will Exarta Therapeutics IPO soon?
No public IPO plans have been announced for Exarta Therapeutics.
How can I track Exarta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Exarta Therapeutics's shares on secondary markets.